American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) . Washington, DC: APA.
Beck, A. T., Ward, C. H., Mendelson, M., et al (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.
Berndt, E. R., Koran, L. M., Finkelstein, S. N., et al (2000) Lost human capital from early-onset chronic depression. American Journal of Psychiatry, 157, 940–947.
British Medical Association & Royal Pharmaceutical Society of Great Britain (1999) British National Formulary.
London & Wallingford: BMJ Books & Pharmaceutical Press.
Delaney, B. C., Wilson, S., Roberts, L., et al (2000) Cost-effectiveness of initial endoscopy for dyspepsia in patients over age 50 years; a randomised controlled trial in primary care. Lancet, 356, 1965–1969.
Depression Guideline Panel (1993) Clinical Practice Guideline, Number 5: Depression in Primary Care, Volume 2: , pp. 45–103. Rockville, MD: US Department of Health and Human Services.
DeRubeis, R. J., Gelfand, L. A., Tang, T. Z., et al (1999) Medication versus cognitive behaviour therapy for severely depressed out-patients: mega-analysis of four randomised comparisons. American Journal of Psychiatry, 156, 1007–1013.
Donaghue, J. (1999) Health economics. In Depressive Disorders (eds May, M. & Sartorius, N.), pp. 454–459. Chichester: John Wiley & Sons.
Efron, B. & Tibshirani, R. (1993) An Introduction to the Bootstrap.
New York: Chapman and Hall.
Elkin, I., Shea, M., Watkins, J., et al (1989) National Institute of Mental Health Treatment of Depression Collaborative Research Programme: general effectiveness of treatment. Archives of General Psychiatry, 46, 971–982.
Evans, M., Hollon, S., DeRubeis, R., et al (1992) Differential relapse following cognitive therapy and pharmacotherapy. Archives of General Psychiatry, 49, 802–809.
Fava, G. A., Rafanelli, C., Grandi, S., et al (1998) Six year outcome for cognitive behaviour treatment of residual symptoms in major depression. American Journal of Psychiatry, 155, 1443–1445.
Gabbard, G. O., Lazar, S. G., Hornberger, J., et al (1997) The economic impact of psychotherapy. American Journal of Psychiatry, 154, 147–155.
Greenberg, P. E., Stiglin, L. E., Finkelstein, S. N., et al (1993) The economic burden of depression in 1990. Journal of Clinical Psychiatry, 54, 405–418.
Hamilton, M. (1967) Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology, 6, 278–296.
Howland, R. H. (1993) Chronic depression. Hospital and Community Psychiatry, 44, 633–639.
Johnsson, B. & Bebbington, P. E. (1994) What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. British Journal of Psychiatry, 164, 665–673.
Knapp, M. & Beecham, J. (1990) Costing mental health services: the client service receipt inventory. Psychological Medicine, 20, 893–908.
McCoombs, J., Stimmel, G., Hui, R., et al (2001) The economic impact of treatment on-response in major depressive disorders. In Treatment-Resistant Mood Disorders (eds Amsterdam, J., Hornig, M. & Nierbenberg, A.), pp. 491–503. Cambridge: Cambridge University Press.
Murray, C. J. & Lopez, A. D. (1996) The Global Burden of Disease. A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020.
Cambridge, MA: Harvard University Press.
Netten, A., Dennet, J. & Knight, J. (1999) Unit Costs of Health and Social Care.
Canterbury: University of Kent, Personal Social Services Research Unit.
Paykel, E. S., Scott, J., Teasdale, J., et al (1999) Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Archives of General Psychiatry, 56, 829–835.
Rosenbaum, J. F. & Hylan, T. R. (1999) Costs of depressive disorders: a review. Depressive Disorders, 21, 401–449.
Schafer, J. L. (1999) Multiple imputation: a primer. Statistical Methods in Medical Research, 8, 3–15.
Scott, A. I. & Freeman, C. P. (1992) Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ, 304, 883–887.
Scott, J. (2000) New evidence in the treatment of chronic depression. New England Journal of Medicine, 342, 1518–1520.
Scott, J., Teasdale, J. D., Paykel, E. S., et al (2000) Effects of cognitive therapy on psychological symptoms and social functioning in residual depression. British Journal of Psychiatry, 177, 440–446.
Simon, G. E., Von Korff, M. & Barlow, W. (1995) Health care costs of primary care patients with recognised depression. Archives of General Psychiatry, 52, 850–856.
Statistical Solutions (1999) SOLAS for Missing Data Analysis 2.1.
Cork: Statistical Solutions.
Sturm, R. & Wells, K. B. (1995) How can care for depression become more cost-effective?
Journal of the American Medical Association, 273, 51–58.
Thompson, S. G. & Barber, J. A. (2000) How should cost data in pragmatic randomised controlled trials be analysed?
BMJ, 320, 1197–2000.
UK Prospective Diabetes Study Group (1998) Cost-effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ, 317, 720–726.
van Hout, B. A., Al, M. J., Gordon, G. S., et al (1994) Costs, effects and C/E-ratios alongside a clinical trial. Health Economics, 3, 309–319.
Wells, K. B., Sturm, R., Sherbourne, C. D., et al (1996) Caring for Depression, pp. 121–210. Cambridge, MA: Harvard University Press.